Neuca (LTS:0MJR) Beneish M-Score: -2.65 (As of Jun. 26, 2026)


LTS:0MJR Neuca SA LTS:0MJR
98 GF Score
Price zł760.00
GF Value zł938.86
! 4 Warning Signs
View Full Analysis

What is Neuca Beneish M-Score?

Neuca LTS:0MJR 98 Beneish M-Score is -2.65 as of Jun. 26, 2026. GuruFocus rates LTS:0MJR with a GF Score™ of 98/100 and a GF Value™ of zł938.86. The stock has 4 warning signs investors should review. Among 113 Medical Distribution companies, Neuca ranks better than 65.49% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.65 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Neuca's Beneish M-Score or its related term are showing as below:

LTS:0MJR' s Beneish M-Score Range Over the Past 10 Years
Min: -2.82   Med: -2.51   Max: 4.4
Current: -2.65

During the past 13 years, the highest Beneish M-Score of Neuca was 4.40. The lowest was -2.82. And the median was -2.51.


Neuca Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Neuca's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Beneish M-Score Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.52 -2.49 -2.62 -2.34 -2.71

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.38 -2.47 -2.49 -2.71 -2.65

LTS:0MJR vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Neuca's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuca Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Neuca's Beneish M-Score falls into.


LTS:0MJR
98GF Score
Neuca SA LTS:0MJR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuca Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Neuca for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0014+0.528 * 0.9934+0.404 * 0.9545+0.892 * 1.0795+0.115 * 1.0246
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0023+4.679 * -0.043258-0.327 * 1.0703
=-2.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was zł2,056 Mil.
Revenue was 3556.906 + 3520.863 + 3488.826 + 3268.038 = zł13,835 Mil.
Gross Profit was 428.001 + 392.249 + 400.635 + 374.739 = zł1,596 Mil.
Total Current Assets was zł4,038 Mil.
Total Assets was zł6,136 Mil.
Property, Plant and Equipment(Net PPE) was zł742 Mil.
Depreciation, Depletion and Amortization(DDA) was zł128 Mil.
Selling, General, & Admin. Expense(SGA) was zł1,299 Mil.
Total Current Liabilities was zł4,493 Mil.
Long-Term Debt & Capital Lease Obligation was zł149 Mil.
Net Income was 68.342 + 27.119 + 60.246 + 19.847 = zł176 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = zł0 Mil.
Cash Flow from Operations was -5.164 + 168.952 + 89.732 + 187.443 = zł441 Mil.
Total Receivables was zł1,902 Mil.
Revenue was 3365.888 + 3220.956 + 3185.245 + 3043.423 = zł12,816 Mil.
Gross Profit was 390.722 + 352.699 + 369.544 + 355.407 = zł1,468 Mil.
Total Current Assets was zł3,511 Mil.
Total Assets was zł5,462 Mil.
Property, Plant and Equipment(Net PPE) was zł687 Mil.
Depreciation, Depletion and Amortization(DDA) was zł122 Mil.
Selling, General, & Admin. Expense(SGA) was zł1,201 Mil.
Total Current Liabilities was zł3,716 Mil.
Long-Term Debt & Capital Lease Obligation was zł145 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2055.982 / 13834.633) / (1901.83 / 12815.512)
=0.148611 / 0.148401
=1.0014

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1468.372 / 12815.512) / (1595.624 / 13834.633)
=0.114578 / 0.115335
=0.9934

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4038.153 + 742.028) / 6135.546) / (1 - (3511.015 + 686.673) / 5461.684)
=0.220904 / 0.23143
=0.9545

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=13834.633 / 12815.512
=1.0795

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(122.236 / (122.236 + 686.673)) / (128.363 / (128.363 + 742.028))
=0.151112 / 0.147477
=1.0246

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1299.012 / 13834.633) / (1200.59 / 12815.512)
=0.093896 / 0.093683
=1.0023

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((148.963 + 4493.384) / 6135.546) / ((145.084 + 3715.934) / 5461.684)
=0.756631 / 0.706928
=1.0703

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(175.554 - 0 - 440.963) / 6135.546
=-0.043258

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Neuca has a M-score of -2.65 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.65 mean?
Neuca (LTS:0MJR) has a Beneish M-Score of -2.65 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Neuca and its competitors. According to the industry distribution chart, Neuca ranks #39 out of 113 companies in the Medical Distribution industry, placing it in the top 34.5%.
Is Neuca's Beneish M-Score too high?
Neuca's current Beneish M-Score is -2.65. Based on the distribution chart, Neuca ranks #39 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Neuca has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Neuca ranks #39 out of 113 companies for Beneish M-Score. This puts Neuca in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Neuca and its competitors. Neuca's current Beneish M-Score is -2.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (LTS:0MJR) has a current Beneish M-Score of -2.65. The stock's GF Value™ is zł938.86, compared to a current price of zł760.00 — trading 19.1% below its estimated fair value. The current Beneish M-Score is -2.65. Neuca's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current Beneish M-Score is -2.65 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (LTS:0MJR) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł760.00 is trading 19.1% below its estimated GF Value™ of zł938.86.

Key valuation signals for LTS:0MJR:

  • Beneish M-Score: -2.65
  • GF Value™: zł938.86 vs. price of zł760.00 (19.1% below fair value)
  • GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuca Business Description

Other Exchanges NEU:Poland
Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
98GF Score

Get the complete analysis for LTS:0MJR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł760.00
Price
zł938.86
GF Value